Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review

OBJECTIVE: Optimal glucocorticoid-induced hyperglycemia (GCIH) management is unclear. The COVID-19 pandemic has made this issue more prominent because dexamethasone became the standard of care in patients needing respiratory support. This systematic review aimed to describe the management of GCIH an...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Danielle, Schulman-Rosenbaum, Rifka, Griff, Megan, Lester, Janice, Low Wang, Cecilia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AACE. Published by Elsevier Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354392/
https://www.ncbi.nlm.nih.gov/pubmed/35940469
http://dx.doi.org/10.1016/j.eprac.2022.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354392/
https://www.ncbi.nlm.nih.gov/pubmed/35940469
http://dx.doi.org/10.1016/j.eprac.2022.07.014

Ejemplares similares